ClinicalTrials.gg
Not yet recruitingNCT07918365PREMA-PSYUpdated Nov 5, 2026

The Effects of Extreme Prematurity on Parenting

An observational study in Depression Disorder and Post Traumatic Stress Disorder PTSD, sponsored by Centre Hospitalier Universitaire de Besancon. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Centre Hospitalier Universitaire de Besancon · Observational

Updated Nov 5, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Family-based
Time perspective
Prospective
Enrollment
30
Sex
All
01

Study summary

In France, perinatal mental health has become a major public health issue. Maternal mental health conditions can have serious consequences, including death by suicide. Fathers may also experience significant psychological distress during the perinatal period. These difficulties can affect parents' well-being, the developing parent-infant relationship, and family life, highlighting the importance of early identification and appropriate support for both parents.

The birth of an infant before 28 completed weeks of gestation can be a traumatic experience for parents. Concerns about the infant's survival and health, together with the unfamiliar environment of a neonatal intensive care unit, can disrupt the transition to parenthood and may be associated with severe depressive symptoms and childbirth-related post-traumatic stress symptoms.

This single-centre observational study explores the psychological experiences of couples following the birth of an infant before 28 completed weeks of gestation. Its primary objective is to assess childbirth-related post-traumatic stress symptoms using the City Birth Trauma Scale. Secondary objectives are to assess depressive symptoms and explore parental representations, emotional experiences, and psychological functioning.

Couples will be invited to participate during their infant's hospitalisation in the neonatal intensive care unit at Besançon University Hospital, France. Both parents in each couple will participate, with individual assessments taking place at least one month after birth. Each assessment session will last approximately 90 minutes and will include a semi-structured interview using the Clinical Interview for Parents of High-Risk Infants (CLIP), the Rorschach test, and two self-report questionnaires: the Edinburgh Postnatal Depression Scale (EPDS) and the City Birth Trauma Scale, using the appropriate maternal or partner version.

This exploratory study aims to improve understanding of parental psychological vulnerability following extremely preterm birth. In the longer term, its findings may raise healthcare professionals' awareness of maternal and paternal distress and inform approaches to systematic screening for postnatal depression and childbirth-related post-traumatic stress symptoms. Ultimately, this research seeks to support the development of care that addresses both parents' psychological needs and promotes early parent-infant relationships.

02

Conditions studied

  • Depression Disorder
  • Post Traumatic Stress Disorder PTSD

Browse trials for

03

In context

Combat Disorders

200 studies on the registry are indexed under Combat Disorders; 90 are open to participants now.

This study's planned enrollment of 30 is below the median of 140 across 26 observational studies indexed under Combat Disorders.

Browse Combat Disorders studies →

Lead sponsor

Centre Hospitalier Universitaire de Besancon is the lead sponsor of 450 studies on the registry; 97 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Probability sample

Study population

Parent of a baby born at or before 28 weeks' gestation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • To have recently become the parent of a baby born at or before 28 weeks' gestation
  • To be proficient in French
  • To have signed the study consent form

Exclusion criteria

Exclusion Criteria:

  • - Persons deprived of their liberty by judicial or administrative decision; persons receiving involuntary psychiatric care
  • Adults subject to a legal protection measure or unable to express their consent
  • Patients who are not proficient in French
  • Refusal to participate in the study
05

Study design

Observational model
Family-based
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Childbirth related post-traumatic stress disorder

    The City Birth Trauma Scale (City BiTS) is a self-report questionnaire assessing childbirth-related post-traumatic stress symptoms according to DSM-5 criteria. It explores traumatic exposure, re-experiencing, avoidance, negative cognitions and mood, hyperarousal, symptom duration, distress, and functional impairment. Its 20 symptom items are scored from 0 to 3, yielding a total symptom score ranging from 0 to 60, with higher scores indicating greater symptom severity. In this study, the French versions for mothers and partners will be administered following very preterm birth. Total symptom scores will be analysed as a continuous measure. The questionnaire does not independently establish a clinical diagnosis of post-traumatic stress disorder.

    Time frame: November 2026 to May 2027

Secondary outcomes

  1. Postnatal Depression

    The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire assessing depressive symptoms over the past seven days. Each item is scored from 0 to 3, yielding a total score ranging from 0 to 30, with higher scores indicating greater symptom severity. It includes an item assessing thoughts of self-harm. In this study, the French version will be administered to mothers and fathers following very preterm birth to assess parental depressive symptoms. Total scores will be analysed as a continuous measure. The EPDS is a screening instrument and does not establish a clinical diagnosis of depression.

    Time frame: November 2026 to May 2027

Other outcomes

  1. Parental psychological functioning assessed using the Rorschach test

    The Rorschach test is a projective psychological assessment comprising 10 standardized inkblot cards. Participants describe what each inkblot might represent, followed by an inquiry to clarify their responses. Responses are coded and interpreted according to the French School (Paris School) approach, considering perceptual features, response content, and qualitative aspects of the protocol. In this study, it will be used to explore parental psychological functioning, with particular attention to emotional processing, defensive processes, and psychic boundaries in the context of very preterm birth. Findings will contribute to an exploratory assessment of psychological containment, protection, and differentiation. No single overall score or diagnostic cutoff will be used.

    Time frame: November 2026 to May 2027

07

Study locations

No study locations are listed for this record.

08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07918365
Responsible party
Sponsor
First posted
Nov 5, 2026
Start date
Nov 2, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Nov 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion